Wobbly Wednesday sends stocks lower 📉

The market edged into the red on Wednesday, as it continues to face stiff resistance around its latest record high.                                                                                                                                                                                                                                                                                                                                                                                                                 February 28, 2024 | [Read Online]( Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today. Markets 📈 Stocks turned south on Wednesday as the market continued to break through a stiff resistance level. The Nasdaq and Russ2K underperformed. - DJIA [<0.1%] - S&P 500 [-0.1%] - Nasdaq [-0.5%] - Russell 2K [-0.7%] [Prediction: Top 4 Trades for 2024]( (ad) 2024 can be your most profitable year as an investor . . . If you know where the breakthrough opportunities are and if you get in on them soon enough. AI is still the catalyst. But forget about chip stocks like Nvidia. That frenzy has cooled. The next wave of AI domination is emerging now — and you may be shocked by where the most explosive gains will come from. Our 2024 Profit Predictions Report reveals 4 exciting tickers you need to see right away. [Get the FREE Report on the NEXT PAGE »]( » Want an Ad-Free Experience + Top Growth Stock Picks? [Upgrade Now!]( Market-Moving News 🔎 🍔 Wendy's Dabbles in Dinner Date Dynamics Wendy's [WEN +1.8%], the iconic home of the square patty, recently shared its full-year earnings, and while investors gave a collective shrug with a slight 1.5% stock dip, it was something CEO Kirk Tanner mentioned that's now cooking up a storm. Surge Pricing for Burgers 📈 Dynamic pricing, or "surge pricing" for the uninitiated, isn't just for your late-night Uber escapades anymore. Airlines have been playing this game since the '80s, adjusting prices based on demand to maximize profits and, theoretically, distribute services more efficiently. But while snagging a seat on a plane using this model is one thing, seeing it applied to your burger and fries is quite another. The fast-food faithful aren't exactly thrilled at the prospect of their drive-thru orders fluctuating with the weather, time of day, or how desperately they need a Frosty fix. Damage Control 🚨 In response to the uproar, Wendy's was quick to throw water on the grease fire, clarifying that their exploration into dynamic pricing wasn't about jacking up prices during lunch rush hour but about innovation and meeting consumer demand. They're sticking to their story that price hikes when everyone wants a burger is not on the menu. But let's face it, the damage might already be done. A Super-Sized Problem 🍟 This whole debacle couldn't come at a worse time for Wendy's. With a measly 0.9% growth in comparable sales and a 4.5% dip in earnings per share, they're already the underdog compared to the fast-food royalty of McDonald's and the resurgent Burger King. Add to that the pressure from Trian Fund Management and Nelson Peltz to clean up their act, and Wendy's is in a pickle—and not just the kind you find on a burger. Only time will tell if Wendy's can turn this PR blip into a boon or if it'll be remembered as the time fast food got too smart for its own good. Market-Moving News 🔎 🍔 Wendy's Dabbles in Dinner Date Dynamics Wendy's [WEN +1.8%], the iconic home of the square patty, recently shared its full-year earnings, and while investors gave a collective shrug with a slight 1.5% stock dip, it was something CEO Kirk Tanner mentioned that's now cooking up a storm. Surge Pricing for Burgers 📈 Dynamic pricing, or "surge pricing" for the uninitiated, isn't just for your late-night Uber escapades anymore. Airlines have been playing this game since the '80s, adjusting prices based on demand to maximize profits and, theoretically, distribute services more efficiently. But while snagging a seat on a plane using this model is one thing, seeing it applied to your burger and fries is quite another. The fast-food faithful aren't exactly thrilled at the prospect of their drive-thru orders fluctuating with the weather, time of day, or how desperately they need a Frosty fix. Cue a media frenzy and a less-than-flattering portrayal by The New York Post, accusing Wendy's of trying to milk inflation-stricken Americans for all they're worth.Damage Control 🚨 In response to the uproar, Wendy's was quick to throw water on the grease fire, clarifying that their exploration into dynamic pricing wasn't about jacking up prices during lunch rush hour but about innovation and meeting consumer demand. They're sticking to their story that price hikes when everyone wants a burger is not on the menu. But let's face it, the damage might already be done. A Super-Sized Problem 🍟 This whole debacle couldn't come at a worse time for Wendy's. With a measly 0.9% growth in comparable sales and a 4.5% dip in earnings per share, they're already the underdog compared to the fast-food royalty of McDonald's and the resurgent Burger King. Add to that the pressure from Trian Fund Management and Nelson Peltz to clean up their act, and Wendy's is in a pickle—and not just the kind you find on a burger. So as Wendy's flirts with the idea of "Happy Hour" pricing, the rest of us are left wondering if our next fast-food run will require budgeting skills worthy of a Wall Street trader. Only time will tell if Wendy's can turn this PR blip into a boon or if it'll be remembered as the time fast food got too smart for its own good. Top Winners and Losers 🔥 Vivani Medical [VANI] $3.74 (270.3%) said a preclinical trial showed its under-the-skin drug implant helped reduce weight in obese mice. vTv Therapeutic [VTVT] $16.65 (+95.8%) closed a $51 million private placement offering of its shares to a group of healthcare-focused institutional investors. Adial Pharma [ADIL] $1.62 (+85.5%) was granted a U.S. patent covering its lead investigational drug AD04 and its ability to target the serotonin transporter gene for the potential treatment of opioid use disorder (OUD). Oragenics [NERV] $1.42 (42.0%) registered for a $2.1 million offering of roughly 1.4 million shares of its common stock. Integral Ad Sci. [IAS] $10.01 (41.4%) saw several analysts cut their price targets on the stock after its Q4 results were published late Tuesday, despite surpassing consensus estimates for both earnings & revenues. Palatin [PTN] $2.45 (38.2%) said its PL9643 dry eye drug candidate didn’t achieve statistical significance in a MELODY-1 pivotal Phase 3 clinical trial. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, — Adam G. Elite Trade Club Text ELITESTOCKS to 47121 or [click here]( to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign Up for Mobile Alerts Now]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America